Endpoints News 8. Apr. 2026 David Sinclair startup Life Biosciences raises $80M for clinical test of anti-aging gene therapy
Endpoints News 8. Apr. 2026 European VC Jeito gets $1.2B to help private biotechs control their 'destiny'
Endpoints News 7. Apr. 2026 White House adds AbbVie's Humira to TrumpRx alongside cheaper biosimilars
Endpoints News 7. Apr. 2026 ARPA-H selects three teams in $100M effort to repair and regrow ailing joints
Endpoints News 7. Apr. 2026 Terns sold to Merck for 13% lower than pharma's initial offer because of clinical data
Endpoints News 7. Apr. 2026 Novo launches high-dose Wegovy in the US; Evotec pressured to list its US unit
Endpoints News 7. Apr. 2026 Sanofi bispecific sails through asthma, sinusitis trials, but disappoints in eczema
Endpoints News 6. Apr. 2026 Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
Endpoints News 6. Apr. 2026 Anthropic pays $400M for biotech; Praxis epilepsy drug hits in Phase 1/2 trial